申请人:CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
公开号:US10555949B2
公开(公告)日:2020-02-11
The present invention relates to a pyrrolopyrimidine compound as TLR7 agonist, and particularly relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, a preparation process thereof, a pharmaceutical composition containing such compounds and use thereof for manufacturing a medicament against viral infection.
本发明涉及一种作为 TLR7 激动剂的吡咯并嘧啶化合物,特别是涉及一种式(I)化合物或其药学上可接受的盐、其制备工艺、含有这种化合物的药物组合物及其用于制造抗病毒感染药物的用途。